U.S. Markets close in 1 hr 26 mins

Antares Pharma, Inc. (ATRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.9800+0.0600 (+1.53%)
As of 2:31PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.9200
Open3.9300
Bid3.9600 x 1800
Ask3.9700 x 1800
Day's Range3.8800 - 4.0500
52 Week Range2.3100 - 5.0700
Volume454,437
Avg. Volume1,366,066
Market Cap669.281M
Beta (5Y Monthly)1.48
PE Ratio (TTM)12.06
EPS (TTM)0.3300
Earnings DateMar 02, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.42
  • Antares Pharma's (NASDAQ:ATRS) Wonderful 344% Share Price Increase Shows How Capitalism Can Build Wealth
    Simply Wall St.

    Antares Pharma's (NASDAQ:ATRS) Wonderful 344% Share Price Increase Shows How Capitalism Can Build Wealth

    Buying shares in the best businesses can build meaningful wealth for you and your family. And highest quality companies...

  • Antares Pharma (ATRS) Q4 Earnings Lag Estimates
    Zacks

    Antares Pharma (ATRS) Q4 Earnings Lag Estimates

    Antares Pharma (ATRS) delivered earnings and revenue surprises of -25.00% and 7.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Benzinga

    Recap: Antares Pharma Q4 Earnings

    Shares of Antares Pharma (NASDAQ:ATRS) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were flat 0.00% over the past year to $0.03, which were in line with the estimate of $0.03. Revenue of $44,133,000 up by 16.63% from the same period last year, which beat the estimate of $40,750,000. Outlook The upcoming fiscal year's revenue expected to be between $175,000,000 and $200,000,000. Conference Call Details Date: Mar 02, 2021 View more earnings on ATRS Time: 08:30 AM ET Webcast URL: https://streaming.webcasts.com/starthere.jsp?ei=1424766&tp_key=38c62cb12a Technicals Company's 52-week high was at $5.07 52-week low: $1.60 Price action over last quarter: Up 57.89% Company Description Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For March 2, 2021Antares Pharma's Earnings: A Preview© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.